APA (7th ed.) Citation

Vincenzo Raimondi, Nicolas Thomas Iannozzi, Jessica Burroughs-Garcìa, Denise Toscani, Paola Storti, & Nicola Giuliani. (2022). A personalized molecular approach in multiple myeloma: The possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors. Open Exploration Publishing Inc..

Chicago Style (17th ed.) Citation

Vincenzo Raimondi, Nicolas Thomas Iannozzi, Jessica Burroughs-Garcìa, Denise Toscani, Paola Storti, and Nicola Giuliani. A Personalized Molecular Approach in Multiple Myeloma: The Possible Use of RAF/RAS/MEK/ERK and BCL-2 Inhibitors. Open Exploration Publishing Inc., 2022.

MLA (9th ed.) Citation

Vincenzo Raimondi, et al. A Personalized Molecular Approach in Multiple Myeloma: The Possible Use of RAF/RAS/MEK/ERK and BCL-2 Inhibitors. Open Exploration Publishing Inc., 2022.